LEDGF/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis
- 17 June 2003
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 2 (5) , 290-297
- https://doi.org/10.1016/s1568-9972(03)00063-6
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Disposal of dying cells: A balancing act between infection and autoimmunityArthritis & Rheumatism, 2003
- Prevention and Induction of Autoimmune Exocrinopathy Is Dependent on Pathogenic Autoantigen Cleavage in Murine Sjögren’s SyndromeThe Journal of Immunology, 2002
- Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: Implications for systemic autoimmunityArthritis & Rheumatism, 2001
- Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditionsJournal of Allergy and Clinical Immunology, 2000
- Cleavage by Granzyme B Is Strongly Predictive of Autoantigen StatusThe Journal of Experimental Medicine, 1999
- Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune diseaseCell Death & Differentiation, 1999
- Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigensArthritis & Rheumatism, 1998
- Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probesCell Death & Differentiation, 1998
- Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis.The Journal of Experimental Medicine, 1996
- DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis.The Journal of Experimental Medicine, 1995